- Membership & Partners
- Education & Events
|Prostate Cancer Screening Decision Aides|
ACPM received funding from the National Center for Chronic Disease Prevention and Health Promotion to develop materials that promote and enhance informed decision making for men considering prostate cancer screening decisions and their providers.
The decision aids:
The patient Decision Guide is available for providers to print and use.
The accompanying Provider Guide includes updated evidence about the potential benefits and harms of screening with the PSA test and helps prepare primary care physicians for discussions with patients.
Pilot Test Study
ACPM embarked on a pilot test study of the decision aid tool at Duke University to determine the impact of the decision aid tool on the shared decision making process between a patient and provider when deciding on prostate-specific antigen (PSA) screening for prostate cancer. The pilot study was designed to allow refinement of the decision aid tool and collect necessary preliminary data to enhance the tool’s impact and usability. The overarching goal was to minimize decisional conflict as men make an informed and shared decision regarding prostate cancer screening.
ACPM and CDC assembled a small panel of experts to serve as advisers to the project. The panel includes experts in prostate cancer and decision aids to discuss current evidence and content in developing decision aids; in patient communication to examine options for modality (web app, videos, devices, etc.) and discuss considerations related to patient communication, health literacy, etc.; and in representing the clinical provider community to discuss needs, facilitators, and barriers to providers using decision aids in primary care settings. Panel members include: